Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression

Nonalcoholic fatty liver disease or steatohepatitis (NAFLD/NASH) is a fatty liver disease that is closely related to obesity, diabetes, and dyslipidemia. Pioglitazone, which was developed as an antidiabetic drug, is known to improve NALFD. Pioglitazone is metabolized by multiple cytochrome P450 (CYP...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Hwa Young, Kim, Hwan Hee, Hwang, Ji-Yeon, Park, Changhun, Cho, Bo Youn, Park, Young Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181001/
https://www.ncbi.nlm.nih.gov/pubmed/30363699
http://dx.doi.org/10.1155/2018/9568269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181001/
https://www.ncbi.nlm.nih.gov/pubmed/30363699
http://dx.doi.org/10.1155/2018/9568269

Ejemplares similares